Liver disease due to Hepatitis B and C represent the foremost health challenge confronting Asia, and Pakistan in particular. It is responsible for high morbidity and mortality in our population. Other liver diseases, such as non-alcoholic steatohepatitis have assumed alarming proportions globally, and high prevalence of liver cancer and other cirrhotic complications underline the need for the timely detection and treatment of hepatitis, and its consequences.
This course is a comprehensive blended learning programme, and is a combination of face-to-face sessions, and online assignments, to ensure up-to-date and evidence based management of patients with liver disease.
The course aims to:
- create awareness about the rising incidence of hepatitis infection in the community, and the need of prevention
- understand and correctly interpret the various investigations available for the diagnosis of hepatitis B and C
- understand the evidence based guidelines for the treatment of HBV and HCV
- understand the pathophysiology and treatment options in NASH and HCC
- review the complications of cirrhosis and its management strategies
- General physicians, registered with the PMDC, and active in the management of hepatitis patients
- Internal medicine and Gastroenterology trainees
Dr Faisal Wasim Ismail, Associate Professor, Gastroenterology, Department of Medicine
March 4-25, 2020 | Every Wednesday | 3:00 pm to 5:00 pm
Department of Medicine in collaboration with Department of Continuing Professional Education